JPH0131485B2 - - Google Patents

Info

Publication number
JPH0131485B2
JPH0131485B2 JP56115817A JP11581781A JPH0131485B2 JP H0131485 B2 JPH0131485 B2 JP H0131485B2 JP 56115817 A JP56115817 A JP 56115817A JP 11581781 A JP11581781 A JP 11581781A JP H0131485 B2 JPH0131485 B2 JP H0131485B2
Authority
JP
Japan
Prior art keywords
miconazole
gel
peppermint oil
cream
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56115817A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5815909A (ja
Inventor
Takuzo Joge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toko Yakuhin Kogyo KK
Original Assignee
Toko Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14671831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0131485(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toko Yakuhin Kogyo KK filed Critical Toko Yakuhin Kogyo KK
Priority to JP56115817A priority Critical patent/JPS5815909A/ja
Priority to EP82106376A priority patent/EP0070525B1/en
Priority to DE8282106376T priority patent/DE3275059D1/de
Priority to CA000407775A priority patent/CA1174601A/en
Priority to DK328082A priority patent/DK158930C/da
Priority to ES514214A priority patent/ES8401850A1/es
Publication of JPS5815909A publication Critical patent/JPS5815909A/ja
Publication of JPH0131485B2 publication Critical patent/JPH0131485B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP56115817A 1981-07-22 1981-07-22 抗真菌外用剤 Granted JPS5815909A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP56115817A JPS5815909A (ja) 1981-07-22 1981-07-22 抗真菌外用剤
EP82106376A EP0070525B1 (en) 1981-07-22 1982-07-15 Fungicidal preparations for external use
DE8282106376T DE3275059D1 (en) 1981-07-22 1982-07-15 Fungicidal preparations for external use
CA000407775A CA1174601A (en) 1981-07-22 1982-07-21 Pharmaceutical preparations for external use
DK328082A DK158930C (da) 1981-07-22 1982-07-21 Fremgangsmaade til fremstilling af antifungalt farmaceutisk praeparat til ekstern anvendelse
ES514214A ES8401850A1 (es) 1981-07-22 1982-07-21 Un preparado farmaceutico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56115817A JPS5815909A (ja) 1981-07-22 1981-07-22 抗真菌外用剤

Publications (2)

Publication Number Publication Date
JPS5815909A JPS5815909A (ja) 1983-01-29
JPH0131485B2 true JPH0131485B2 (OSRAM) 1989-06-26

Family

ID=14671831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56115817A Granted JPS5815909A (ja) 1981-07-22 1981-07-22 抗真菌外用剤

Country Status (6)

Country Link
EP (1) EP0070525B1 (OSRAM)
JP (1) JPS5815909A (OSRAM)
CA (1) CA1174601A (OSRAM)
DE (1) DE3275059D1 (OSRAM)
DK (1) DK158930C (OSRAM)
ES (1) ES8401850A1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244027A1 (de) * 1982-11-27 1984-05-30 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von gelsystemen
JPS6058914A (ja) * 1983-09-12 1985-04-05 Shionogi & Co Ltd イミダゾ−ル系抗真菌性外用ゲル製剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
CS253719B2 (en) * 1984-03-07 1987-12-17 Janssen Pharmaceutica Nv Emulsible concentrate with fungicide activity and process for preparing thereof
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
HU200914B (en) * 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
GB2208598A (en) * 1987-08-15 1989-04-12 Ciba Geigy Ag Antimicrobial preparations for external use
GB8921710D0 (en) * 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
US5240932A (en) * 1990-03-30 1993-08-31 Yasunori Morimoto Percutaneously absorbable compositions of morphine or analogous analgesics of morphine
JPH07179341A (ja) * 1993-12-22 1995-07-18 Toko Yakuhin Kogyo Kk 安定なミコフェノール酸含有皮膚外用剤
JP3081766B2 (ja) * 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
FR2721515B1 (fr) * 1994-06-28 1996-09-13 Fabre Pierre Cosmetique Composition pharmaceutique antibactérienne.
FR2722689B1 (fr) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant
FR2728791B1 (fr) * 1995-01-03 1997-03-21 Fabre Pierre Dermo Cosmetique Produit antifongique contenant du crotamiton, composition antifongique et utilisation a titre de medicament
RU2190394C1 (ru) * 2001-11-08 2002-10-10 ОАО Нижегородский химико-фармацевтический завод Фармацевтический состав, обладающий противогрибковой активностью, и способ его получения
DE60221903T2 (de) * 2002-03-25 2008-05-08 Council Of Scientific And Industrial Research Verwendung synergistischer formulierungen von antifungusmitteln für die behandlung von pilzinfektionen
JP4731472B2 (ja) * 2004-02-27 2011-07-27 久光製薬株式会社 徐放性クリーム剤
US7597913B2 (en) * 2004-10-04 2009-10-06 Marc Selner Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
NZ571818A (en) 2006-03-08 2011-10-28 Nihon Nohyaku Co Ltd External pharmaceutical composition comprising luliconazole and an alpha-hydroxycarboxylic acid such as lactic acid, glycolic acid or malic acid.
CA2645070C (en) 2006-03-08 2014-02-04 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
EP2191828B1 (en) 2007-09-05 2016-08-10 Pola Pharma Inc. Antifungal pharmaceutical composition
JP5345937B2 (ja) 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
JP5743375B2 (ja) * 2008-09-30 2015-07-01 小林製薬株式会社 カンジダ症予防又は治療剤
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
CA2909995C (en) * 2013-05-03 2021-04-13 Lipidor Ab Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
CN111358751B (zh) * 2018-12-25 2023-04-18 沈阳兴齐眼药股份有限公司 眼用药物组合物、眼用药盒及其医药用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925407A (en) * 1960-08-02 1963-05-08 Geigy Ag J R Dermatological preparations containing corticosteroids
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
JPS5039664A (OSRAM) * 1973-08-15 1975-04-11
US4123542A (en) * 1977-01-19 1978-10-31 Syntex (U.S.A.) Inc. Derivatives of N-alkyl imidazoles
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
DE2851116A1 (de) * 1978-11-25 1980-06-12 Bayer Ag Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2918897A1 (de) * 1979-05-10 1980-11-20 Bayer Ag Antimikrobielle mittel
DE2928968A1 (de) * 1979-07-18 1981-02-12 Bayer Ag Antimikrobielle mittel
DE2931778A1 (de) * 1979-08-04 1981-02-19 Bayer Ag Antimikrobielle mittel
DE2946957A1 (de) * 1979-11-21 1981-06-04 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
GB2068228B (en) * 1980-01-24 1984-02-29 Janssen Pharmaceutica Nv Anti-microbial compositions for the topical treatment of acne vulgaris
DE3030323A1 (de) * 1980-08-11 1982-03-11 Syntex (U.S.A.) Inc., 94304 Palo Alto, Calif. Die verwendung von imidazolderivaten als spermatostatika oder spermizide

Also Published As

Publication number Publication date
EP0070525A2 (en) 1983-01-26
EP0070525B1 (en) 1987-01-14
ES514214A0 (es) 1984-01-01
EP0070525A3 (en) 1984-01-11
DK328082A (da) 1983-01-23
JPS5815909A (ja) 1983-01-29
DK158930C (da) 1991-01-21
CA1174601A (en) 1984-09-18
ES8401850A1 (es) 1984-01-01
DE3275059D1 (en) 1987-02-19
DK158930B (da) 1990-08-06

Similar Documents

Publication Publication Date Title
JPH0131485B2 (OSRAM)
JP3081766B2 (ja) 角質貯留型抗真菌外用組成物
US5519059A (en) Antifungal formulation
JPH042570B2 (OSRAM)
WO1996011002A1 (fr) Agent anti-inflammatoire a usage externe
JPS6135166B2 (OSRAM)
EP0957906B1 (en) Local anesthetic for external use
JPS6061518A (ja) ゲル状外用組成物
JP4195178B2 (ja) 消炎鎮痛外用剤
JPH0447649B2 (OSRAM)
EP0493496A1 (en) Ibuprofen triturates and topical compositions containing same
JPS62223163A (ja) 尿素を含有する皮膚用組成物
JPH0676328B2 (ja) ステロイドクリ−ム製剤
WO1999001137A1 (fr) Preparation percutanee contenant de l'hydrochlorure d'azelastine, presentant une bonne absorbabilite percutanee et une action d'irritation de la peau reduite
WO2004030665A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin
JPS6218526B2 (OSRAM)
US4961922A (en) Complexes based on anthralin and a sterol, a process for obtaining them and their use in therapeutics and cosmetics
JPS5962518A (ja) 局所用外用剤およびその製造法
JPS62223118A (ja) 外用クリ−ム組成物
JP3571730B2 (ja) サリチル酸配合製剤
EP0253879A1 (en) Topical antiinflammatory compositions
JP2675111B2 (ja) ミノキシジルゲル
JP2844132B2 (ja) 皮膚外用抗菌クリーム製剤
JPS63146817A (ja) 外用抗真菌剤
FR2544198A1 (fr) Compositions pharmaceutiques topiques a base d'acide meclophenamique